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Abstract 
The focus of coagulation as a water treatment process is shifting to 
accommodate recent regulatory additions that strive to balance the risks 
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between microbial and chemical contamination of drinking water. In this 
work, enhanced coagulation using increased ferric chloride dose and/or pH 
adjustment was evaluated for removal efficacy of viruses on the United States 
Environmental Protection Agency (USEPA) Contaminant Candidate List (CCL), 
their surrogates, and dissolved organic carbon (DOC). Jar tests demonstrated 
that optimal DOC removal was achieved using 40 mg/L FeCl3 at a pH between 
5 and 6. Under these conditions, bench-scale testing resulted in a maximum 
removal of 2.58 log units of adenovirus type 4, 2.50 log units of feline 
calicivirus, 2.32 log units of MS2, 1.75 log units of PRD1, 1.52 log units of 
phi-X174, 2.49 log units of fr, and 56% of DOC. The trend in virus removals 
(MS2 and fr > PRD1 and phi-X174) was consistent between bench- and pilot-
scale testing; however, pilot-plant removals exceeded bench-scale removals. 
Feline calicivirus was more efficiently removed than the bacteriophages, 
thereby suggesting potential for the bacteriophages as suitable surrogates, 
with MS2 and fr being more representative and PRD1 and phi-X174 (which 
were removed to a lesser extent) more conservative. The bacteriophages do 
not appear to be appropriate surrogates for adenovirus.  
Introduction 
In an effort to ensure the safety of the nation's drinking water, 
the United States Environmental Protection Agency (USEPA) 
continually develops and re-evaluates regulations targeting drinking 
water contaminants. Individually or in tandem, recently promulgated 
regulations such as the Enhanced Surface Water Treatment Rule 
(ESWTR) and the Disinfectants and Disinfection Byproduct (D/DBP) 
Rule might have important implications for the water treatment 
industry. The ESWTR and D/DBP Rule attempt to simultaneously 
balance the risks posed by microbial and chemical contaminants, 
particularly disinfection byproducts (DBPs). The removal of DBP 
precursors such as dissolved organic carbon (DOC) prior to disinfection 
is an effective means of limiting DBP forma tion. Enhanced coagulation 
was identified by the D/DBP Rule as the best available technology to 
remove DOC.1 Traditional coagulation processes target turbidity 
removal, whereas enhanced coagulation targets the removal of 
turbidity and natural organic matter (NOM) using increased coagulant 
dose and/or pH adjustment.2 The Stage 1 DBP Rule requires many 
systems using surface water or groundwater directly under the 
influence of surface water to implement enhanced coagulation.3 
Enhanced coagulation might become an increasingly important 
treatment process as water utilities adapt their systems to comply with 
the D/DBP Rule.  
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Although a great deal of attention has focused on the removal of 
DBP precursors from drinking water using enhanced coagulation (1, 2, 
4, 5), limited information is available regarding the efficiency of 
enhanced coagulation for the removal of emerging pathogens.6 
Conventional coagulation, flocculation, and sedimentation processes 
have demonstrated efficiency in the removal of a variety of 
microorganisms, including viruses, bacteria, and protozoa.7−9 There is 
a need for similar studies to determine how the optimization of 
enhanced coagulation for the reduction of NOM affects the removal of 
emerging pathogens such as those on the Contaminant Candidate List 
(CCL). The CCL is a list of unregulated contaminants warranting 
priority research because they are believed to occur in public water 
systems and might be associated with adverse health effects. The CCL 
is revised every 5 years in an effort to reflect current priorities. The 
second CCL, which was published in February 2005, includes 9 
microorganisms and 42 chemical contaminants.10  
 
The overall objective of this study was to evaluate the removal 
of adenovirus and calicivirus (CCL viruses) and potential surrogates 
under enhanced coagulation conditions, as defined by DOC removal. 
Adenovirus type 4 and feline calicivirus, which are commonly used 
laboratory surrogates for enteric adenoviruses type 40 and 41 and 
human caliciviruses such as norovirus, were used in this study. Feline 
calicivirus (FCV) is not actually a CCL virus. However, it is the accepted 
laboratory model for studies of the removal and inactivation of human 
caliciviruses, for which an in vitro cell culture technique is not currently 
available.11,12 Thus, FCV was used to represent the physical removal of 
the CCL caliciviruses throughout this study. Future advances in in vitro 
techniques might allow for the direct study of human calicivirus 
removal and inactivation, which would be of great interest.  
 
The results of this study will aid in building a database of the 
efficiencies of treatments of enteric viruses and their surrogates and in 
evaluating CCL viruses in terms of future regulatory determination. In 
this study, bacteriophages representing a range of physical 
characteristics, as listed in Table 1, were selected as potential CCL 
virus surrogates. Microorganisms with removal profiles similar to those 
of the CCL viruses are potential surrogates for the physical removal of 
the CCL viruses. Surrogates would be valuable because in vitro cell 
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culture methods, which are used in the standard assay technique for 
animal viruses, are labor- and time-intensive and require specialized 
equipment and knowledge to perform. Thus, it was important to study 
bacteriophages in an attempt to identify appropriate surrogate 
microorganisms for the CCL viruses.  
Table 1.  Characteristics of CCL Viruses and Potential Surrogate 
Bacteriophages 
bacteriophage bacterial host size (nm) isoelectric 
point 
genetic structure  
MS2 (ATCC 
15597-B1)  
Escherichia coli 
(ATCC 15597)  
2413−2714  3.58−3.913  single-stranded 
RNA  
PRD1 (ATCC 
BAA-769-B1)  
Salmonella 
typhimurium LT2 
(ATCC 19585)  
6214−6515  3.014−4.28  double-stranded 
DNA  
phi-X174 
(13706-B1)  
Escherichia coli 
(ATCC 13706)  
2314−2713  6.613  single-stranded 
DNA  
fr (ATCC 15767-
B1)  
Escherichia coli 
(ATCC 19853)  
2316  8.98−9.08  single-stranded 
RNA 
CCL virus cell line size (nm) isoelectric 
point 
genetic structure  
adenovirus  PLC/PRF/5 (ATCC CRL-
8024)  
7017−10018  −a  double-stranded 
DNA  
feline calicivirus  CRFK (ATCC CCL-94)  2719−4019  −a  single-stranded 
RNA 
aDetermination of the isoelectric point of pathogenic viruses is very difficult, and few 
have been reported. The isoelectric points of adenovirus type 4 and feline calicivirus 
are currently undetermined. 
Materials and Methods 
Source Water and Coagulants.  
 
Untreated water from the Chandler Water Treatment Plant 
(CWTP) in Chandler, AZ, was used as source water throughout this 
investigation. Influent water quality varies throughout the year based 
on a fluctuating blend of surface and groundwater. Water turbidity 
ranged from 3 to 20 NTU, pH from 8 to 8.5, alkalinity from 125 to 200 
mg/L as CaCO3, and DOC from 3 to 6 mg/L. Variations in water quality 
parameters have been reported to significantly impact the 
performance of coagulation, sedimentation, and filtration.17,20  
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Alum and ferric chloride are the most commonly used 
coagulants in water treatment applications.17 Ferric chloride is more 
efficient than alum for NOM removal;17,21 however, there is no 
apparent consensus regarding coagulant selection for microbial 
removal. Alum was used in a related study,8 whereas ferric chloride 
(ferric chloride hexahydrate lumps, Sigma Chemical Co., St. Louis, 
MO) was used in this investigation. A cationic polymer, poly(dial 
lyldimethylammonium chloride) (polyDADMAC; Clarifloc 350, Polydyne, 
Inc., Riceboro, GA), was used in conjunction with ferric chloride to 
improve floc settleability.  
 
Jar Testing.  
 
To simultaneously optimize ferric chloride dose and pH with 
respect to DOC removal, a series of bench-scale jar tests were 
performed. All jar-test experiments were performed using a six-jar PB-
700 Phipps & Bird (Richmond, VA) jar-test apparatus. In addition to 
DOC removal, the removals of four bacteriophages (MS2, PRD1, phi-
X174, and fr), adenovirus type 4, and feline calicivirus were measured 
under enhanced coagulation conditions. Initial tests demonstrated that 
DOC concentrations were distorted by the addition of nutrient media 
from the stock cultures of microorganisms. Thus, separate jar tests 
were conducted under identical enhanced coagulation conditions for 
the bacteriophages, CCL viruses, and DOC. Accordingly, one jar-test 
experiment was conducted to develop the removal profile for the 
bacteriophages, which were assayed in triplicate. Two jar-test 
experiments were conducted using the CCL viruses because time 
limitations prevented duplicate assays of a single experimental 
sample. The two CCL tests are referred to hereafter as the “first and 
second CCL virus experiments”. For each of these three experiments, a 
separate jar-test experiment was performed to analyze DOC removal.  
 
A 10-L sample of untreated water was collected from the CWTP 
for use in each jar-test experiment. The sample was transported and 
stored under darkened conditions at 4 °C. Jar tests were conducted 
within 48 h of sample collection. Prior to experimentation, the sample 
was allowed to return to room temperature (21 °C). The water was 
then seeded with a known number of microorganisms [final 
concentration of 1 × 106 plaque forming units (PFU) per milliliter of 
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each bacteriophage or 1 × 106 50% tissue culture infective dose 
(TCID50) per milliliter of each virus]. The seeded sample was 
thoroughly mixed for 15 min before being distributed in 1.5-L portions 
to each of the jars. The seeded water served as the control with 
respect to initial virus concentrations.  
 
Immediately following microbial seeding, ferric chloride, cationic 
polymer, and 1 N HCl were added to each jar. Ferric chloride doses are 
heavily dependent on water quality and are therefore widely variable.20 
Enhanced coagulation doses range from 5 to 150 mg/L FeCl3,7 but are 
commonly in the range of 20−60 mg/L FeCl3.5 Coagulant doses 
ranging from 0 to 120 mg/L FeCl3 were tested in increments of 20 
mg/L in this study. Polymer was added at a constant dose of 0.4 mg/L. 
Variations in polymer dose have not demonstrated a significant effect 
on DOC removal during enhanced coagulation; therefore, polymer 
dose was held constant.1 The optimal pH for coagulation of NOM with 
ferric chloride is approximately 4−5;2,4 however, for practical reasons, 
enhanced coagulation is generally carried out in a pH range of 5−7.1 
Target pH values ranging from 5.5 to 7.5 were tested using increments 
of roughly 0.5 as part of this investigation.  
 
The jar-testing protocol used throughout this study was based 
on the protocol described by Volk et al.5 Immediately following 
chemical addition, rapid mixing was initiated at 100 rpm for 1 min. 
Mixing was slowed for the flocculation stage, which consisted of two 
10-min mixing periods at 40 and 20 rpm. Finally, the paddles were 
extracted, and the contents of the jars were allowed to settle for 30 
min. Samples were collected from the center of each jar, 
approximately 2 in. below the surface. The samples were immediately 
assayed for bacteriophages, CCL viruses, or DOC; pH; turbidity; and 
ultraviolet absorbance at a wavelength of 254 nm (UV254). UV254 was 
used to calculate specific UV absorbance [SUVA = UV254/DOC, L (mg 
m)-1], which is sometimes used as a surrogate measurement of DBP 
precursors.14  
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Pilot-Plant Facility.  
 
After the coagulant dose and pH had been optimized using the 
jar-test apparatus, pilot-plant experiments were performed at the 
CWTP's pilot-plant facility using the potential surrogate bacteriophages 
(animal viruses were not permitted at the water treatment facility). 
The pilot-plant treatment train includes coagulation, flocculation, 
sedimentation, and filtration. A schematic is provided by Gerba et al.8 
Full-scale plant parameters such as hydraulic residence time (HRT), 
chemical dosing, mixing, and surface loading rates were mimicked by 
the small-scale pilot plant, as shown in Table 1 in the Supporting 
Information. Based on full-scale facility flows, a high flow rate of 0.5 
gpm (1.9 L/min) and a low flow rate of 0.25 gpm (1.0 L/min) were 
selected. The plant was operated for three HRTs prior to sampling such 
that steady-state conditions were achieved (6 and 12 h for the high 
and low flow rates, respectively).  
 
The addition of bacteriophages, ferric chloride, polymer, and HCl 
was regulated using adjustable peristaltic pumps. Seeded water (final 
concentration of 1 × 106 PFU/mL of each bacteriophage) was mixed by 
an inline static mixer before entering a series of three 
coagulation/flocculation chambers separated by diffusion walls, each 
equipped with a propeller-type mixer. The mixers were staged to 
emulate the full-scale plant tapered flocculation sequence using 
progressively lower mixing intensities (35 rpm in the first tank, 
followed by 25 and 15 rpm in the subsequent tanks). The water was 
then directed through the sedimentation basin before entering the dual 
media filters. The filters consisted of 3-in.-diameter acrylic columns 
containing 1.5 ft of gravel support structure, topped with 1 ft of sand, 
followed by 2 ft of granular activated carbon (GAC). Water samples 
were collected at three loca tions:  influent, settled, and filtered. 
Physicochemical parameters were analyzed onsite. The samples were 
transported to the laboratory under darkened conditions at 4 °C and 
were immediately assayed for bacteriophages.  
 
Bacteriophage Propagation and Assays.  
 
The bacterioph ages and bacterial hosts listed in Table 1 were 
obtained from the American Type Culture Collection (ATCC, Rockville, 
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MD). Bacteriophage stocks were propagated using the double agar 
layer (DAL) method.22 Approximately 107 PFU of bacteriophage, 1 mL 
of host bacteria, and 5 mL of 0.7% molten tryptic soy agar (TSA; 
Difco, Detroit, MI) were combined and poured onto 1.5% TSA plates. 
The plates were incubated at 37 °C overnight. Bacteriophage stocks 
were collected the following day by adding 10 mL of 1X phosphate 
buffer saline (PBS) to the surface of the plate and allowing it to 
incubate at room temperature for 1 h. The supernatant was collected 
and centrifuged at 4 °C at 8000g for 15 min. The pellet was discarded, 
and the supernatant containing the bacterioph ages was stored at 
4 °C. Typically, stock concentrations were on the order of 1010 
PFU/mL. New stocks were propagated once the titer dropped below 
108 PFU/mL.  
 
Immediately following jar-test and pilot-plant experi ments, the 
water samples were serially diluted (10-fold) in 1X PBS (sufficient for 
up to 5-log removal) and were promptly assayed in triplicate for 
bacteriophages using the DAL method.22 The plates were incubated at 
37 °C overnight, and plaques were counted after 12 h. Positive and 
negative controls were included in each set of assays for each 
bacteriophage.  
 
CCL Virus Propagation and Assays.  
 
Adenovirus type 4 (Ad4, ATCC VR-4) was obtained from the 
ATCC and was cultured using primary liver cancer cells (PLC/PRF/5, 
ATCC CRL-8024) in 1X Eagle's minimum essential medium (MEM) 
containing 10% fetal bovine serum (FBS). Feline calicivirus (FCV, ATCC 
VR-652) was obtained from the ATCC and was cultured using Crandall 
feline kidney cells (CRFK, ATCC CCL-94) in 1X MEM containing 10% 
equine serum. The 1X MEM was supplemented with 1.5 g/L sodium 
bicarbonate, 15 mM Hepes, 2 mM l-glutamine, 0.1 mM non-essential 
amino acids, 1 mM sodium pyruvate, 100 μg/mL antimycotic, and 100 
μg/mL kanamycin sulfate.  
 
Virus stocks were propagated by inoculating the cells with a 
stock suspension of approximately 1 × 106 TCID50/mL. The flasks were 
incubated at 37 °C until at least 90% of the cells were infected. Cells 
were then subjected to freeze/thaw cycles:  one for Ad4 and three for 
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FCV-infected cells.23 The supernatant was centrifuged at 4 °C at 8000g 
for 15 min to remove cellular debris. The virus suspension was purified 
and concentrated using poly(ethylene glycol) (PEG) precipitation, as 
described by Thurston-Enriquez et al.23 Briefly, the suspension was 
augmented with 9% PEG (MW 8000) and 1 M NaCl and was allowed to 
stir overnight at 4 °C. It was then centrifuged at 4 °C at 8000g for 90 
min. The supernatant was discarded, and the pellet was resuspended 
in 10% of its original volume of 1X PBS. To remove lipids and facilitate 
the monodispersion of viruses, a Vertrel XF (Micro Care Marketing 
Services, New Britain, CT) extraction was performed by centrifuging a 
suspension of equal parts Vertrel and virus at 4 °C at 8000g for 90 
min.23 The supernatant containing the purified viruses was stored at 
−80 °C.  
 
Following jar-test experiments, the water samples were serially 
diluted (10-fold) in 1X PBS (sufficient for up to 4.5-log removal) and 
were promptly assayed using conventional in vitro cell culture 
methodology. Cells were grown in 24-well cell culture trays. Each 
sample dilution was used to inoculate four wells, using 0.1 mL of 
sample per well. The trays were incubated in a 5% CO2 incubator at 
37 °C and were examined daily for any cytopathogenic effects (CPE) 
for up to 14 days. Typically, CPE manifested itself as cell enlargement, 
rounding, and the formation of grape-like clusters.24 The Karber TCID50 
method was used to quantify the viral concentration of each sample. 
The Karber TCID50 equation is a statistical approach used to estimate 
the concentration at which 50% of the inoculated wells are positive for 
infection,24 as follows  
 
 
 
where Δ is the logarithm of the most diluted sample with 100% 
infectivity, α is the logarithm of the dilution factor, and S is the sum of 
the normalized positive infections including both the last 100% and the 
first 0% infectious dilutions.  
 
Chemical Parameter Analysis.  
 
The samples were analyzed for pH, turbidity, DOC, and UV254, all 
of which can affect the efficiency of coagulation. The pH was measured 
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using a Mettler (Columbus, OH) pH meter. Turbidity was measured 
using a Hach (Loveland, CO) model 2100P turbidimeter. For DOC 
determination, samples were filtered using 1.2-μm Whatman 
(Middlesex, U.K.) GF/C glass microfiber filters, acidified using 1 N HCl, 
and analyzed using a Shimadzu 5050A (Kyoto, Japan) Total Organic 
Carbon Analyzer. A Shimadzu Multispec 1501 spectrometer was used 
to measure UV254.  
 
Statistical Analysis.  
 
Statistical analyses were performed to determine whether the 
mean microbial removals resulting from different treatment conditions 
were statistically different at a significance level of α = 0.05. SPSS 
(Chicago, IL) version 12.0 statistical software was used for the 
analyses. An analysis of variance (ANOVA) test was used to test the 
equality of means. The Levene statistic was computed to test the 
ANOVA assumption of equal variances.25 The Welch test of equality of 
means was used for data not satisfying the equal-variance 
assumption.26 Upon determination that the means were significantly 
different, post hoc tests were used to determine which means were 
different from one another. Tukey's honestly significant difference 
(HSD) test was used to test data with equal variances,27 and the 
Games−Howell test was used to analyze data that did not satisfy the 
equal-variances assumption.28  
 
Quality Assurance and Quality Control (QA/QC).  
 
The standard QA/QC procedures for laboratories performing 
microbial and chemical analyses on water samples were followed 
during this research.29,30 Additional details of the QA/QC plan are 
described in each subsection of the Materials and Methods.  
Results and Discussion 
Coagulant Dose-Optimization Jar Tests.  
 
DOC Removal. In all three dose-optimization experiments, 25% 
or greater DOC removal was achieved using coagulant doses of 40 
mg/L or greater FeCl3 (Figures 1 and 2and Tables 2−4 in the 
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Supporting Information), which satisfies the USEPA guidelines for 
enhanced coagulation.3 The guidelines define which utilities are 
required to practice enhanced coagulation, as dictated by initial water 
quality. This particular water would be exempt from the requirement 
based on DOC content in the source water,3 which is an extremely 
important consideration for the full-scale treatment plant. However, 
because the objective was to evaluate virus removal resulting from 
enhanced coagulation, enhanced coagulation condi tions were 
employed throughout this study, and optimization recommendations 
based on DOC removal were made accordingly.  
 
 
Figure 1 Removal of microbes and DOC as a function of FeCl3 dose in the three jar 
tests:  phage test, first CCL virus removal experiment (1), and second CCL virus 
removal experiment (2). The error bars represent ±1 standard deviation for the 
bacteriophages and ±5% for the CCL viruses. The DAL analysis was inconclusive for fr 
at a dose of 20 mg/L. Removals of FCV (1) and FCV (2) at coagulant doses of 100 and 
120 mg/L FeCl3 represent the maximum calculable removals based on the cell culture 
experiment. 
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Figure 2 Removal of microbes and DOC as a function of pH adjustment in the three 
jar tests:  phage test, first CCL virus removal experiment (1), and second CCL virus 
removal experiment (2). The error bars represent ±1 standard deviation for the 
bacteriophages and ±5% for the CCL viruses. A pH range is provided because the final 
pH varied slightly between the jar tests. Because of difficulties adjusting the pH to 
target levels, no data are available for the second (2) CCL virus removal experiment 
for the pH range from 5 to 6. 
The USEPA has established the optimal coagulant dose for DOC 
removal as the point of diminishing return (PODR).3 The PODR is 
defined as the dose at which the change in DOC removal divided by 
the change in coagulant addition drops to (and subsequently remains 
below) 0.03.3 Using the PODR criterion, the optimum ferric chloride 
dose for DOC removal was determined to be 40 mg/L based on the 
bacteriophage experiment, 80 mg/L based on the first CCL virus 
experiment, and 80 mg/L based on the second CCL virus experiment. 
The complete results of the chemical analyses for the dose-
optimization experiments are provided in Tables 2−4 in the Supporting 
Information.  
 
Bacteriophage Removal. Bacteriophage removal generally 
increased as coagulant dose increased (Figure 1). MS2 was generally 
removed to the greatest extent, followed by fr, phi-X174, and PRD1. 
These results are comparable to those of previous studies in that 
male-specific bacteriophages such as MS2 and fr were removed to a 
greater extent than somatic bacteriophages such as PRD1 and phi-
X174 (7, 8, 31).  
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The quantification of virus removal during physical and chemical 
separation processes is well documented.32−34 It appears that the main 
mechanism for the physical removal of viruses is adsorption and 
charge neutralization followed by gravitational separation; however, 
the details of virus adsorption during coagulation and flocculation are 
not yet fully understood. Studies of transport through soil matrices 
have indicated that the adsorption of viruses is a complex process in 
which hydrophobicity, surface charge, and isoelectric point (pI) are 
influential factors.13,34 It appears that no individual factor can 
adequately explain the mech anism of virus adsorption.  
Isoelectric point has been suggested to be the dominant factor 
controlling virus adsorption during transport through sandy soils.13 
Although the complete effects of the addition of coagulant, specifically 
on the surface charge of the virus, are not fully understood, the pI can 
help to explain adsorption during coagulation. The isoelectric points of 
the bacterioph ages are listed in Table 1. The pI of fr is relatively high, 
meaning that its surface is positively charged in most naturally 
occurring pH ranges (6−8). This enables fr to adsorb to the surface of 
negatively charged particles such as Fe(OH)4-. In the same pH range, 
other phages such as MS2 and PRD1 are negatively charged, thereby 
allowing them to adsorb to positively charged species such as 
Fe(OH)2+. Theoretically, as the absolute value between pH and virus pI 
increases, the magnitude of the surface charge increases, thereby 
improving the efficacy of adsorption. This supports the observation 
that MS2 and fr were removed to a greater extent than phi-X174, but 
does not account for the relatively low removal of PRD1. Although the 
exact mechanisms cannot be identified as a result of this study, it is 
apparent that multiple factors contribute to the adsorption and 
resultant removal of viruses during treatment processes.  
 
Statistical analyses were performed using the mean logarithms 
of the removals of the bacteriophages (n = 3) at different coagulant 
doses to determine the optimal dose required to produce a significant 
degree of virus removal (as described in Table 6 in the Supporting 
Information). For each of the four bacteriophages, there was a 
significant difference between the log removal values at different 
coagulant doses (P ≤ 0.01) (Table 5 in the Supporting Information). 
The results indicate that 80 mg/L is the optimal dose for MS2 removal, 
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80 mg/L for PRD1, 40 mg/L for phi-X174, and >120 mg/L for fr (Table 
6 in the Supporting Information).  
 
CCL Virus Removal. The log removal values calculated for the 
two CCL virus removal experiments appear to differ from one another, 
although this could not be verified statistically as the two experiments 
were not regarded as replicates because of differing initial water 
qualities. Overall, FCV was removed to a greater extent than Ad4 
(Figure 1). There was an increase in removal of Ad4 and FCV at a dose 
of 60 mg/L and again at 100 mg/L for the first CCL virus experiment. 
For the second CCL virus experiment, there was an improvement in 
FCV removal at doses of 80 and 100 mg/L, whereas the results for Ad4 
did not clearly identify an optimal dose. This indicates that an optimal 
dose for virus removal might be 60, 80, or 100 mg/L FeCl3, which is 
similar to the range for the bacteriophages.  
 
FCV appeared to be removed to a greater extent than the four 
bacteriophages, thereby indicating that the bacterioph ages might be 
potential surrogates. Bacteriophages MS2 and fr would be more 
representative surrogates, whereas phi-X174 and PRD1 appear to be 
more conservative because they were removed to a lesser extent. 
Adenovirus was not consistently removed to a greater extent than the 
bacteriophages (particularly in the first CCL virus experiment); thus, it 
does not appear that the bacteriophages would be appropriate 
surrogates for Ad4.  
 
In summary, the dose-optimization experiments sug gested a 
wide variation in optimal coagulant doses based on different criteria 
(i.e., from 40 mg/L based on DOC removal to greater than 120 mg/L 
based on the removal of the bacteriophage fr). In light of this result, it 
might be beneficial to consider microbial removal in addition to DOC 
removal when optimizing coagulant doses. However, regulations 
regarding the performance of enhanced coagulation currently refer 
only to DOC removal. Therefore, a dose of 40 mg/L FeCl3 was 
identified as the optimal dose for enhanced coagulation because it was 
the lowest dose shown to produce a significant reduction in DOC 
content. Accordingly, a dose of 40 mg/L FeCl3 was used to conduct the 
pH-optimization jar tests and the pilot-plant study.  
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pH-Optimization Jar Tests.  
 
DOC Removal. The pH-optimization jar tests (Figure 2 and 
Tables 7−9 in the Supporting Information) satisfied the USEPA 
enhanced coagulation guidelines by achieving at least 25% DOC 
removal.3 The optimal pH cannot be determined using the PODR 
calculation, as was done to optimize dose, because the PODR is 
calculated using the change in DOC removal relative to coagulant dose 
increments. However, substantial improve ments in DOC removals 
were observed between pH 6.01 and 5.55 and between pH 6.16 and 
5.73 based on the bacteriophage and the first CCL virus removal 
experiments, respectively. Judging from these experiments, it appears 
that the optimal pH range with respect to DOC removal is less than 
6.0. The complete results of the chemical analyses for the pH-
optimization experiments are provided in Tables 7−9 in the Supporting 
Information.  
 
Bacteriophage Removal. Bacteriophage MS2 was generally 
removed to the greatest extent, followed by fr, phi-X174, and PRD1 
(Figure 2). There was a statistically significant difference between the 
mean log removal values at different pH values for each of the 
bacteriophages tested (P ≤ 0.01) (Table 10 in the Supporting 
Information). The post hoc tests indicate that the optimal pH is less 
than 6.0 for PRD1 removal and less than 5.55 for phi-X174 and fr 
removal, whereas an optimal pH for removal of MS2 could not be 
identified (Table 11 in the Supporting Information).  
 
CCL Virus Removal. Differences in initial water qualities between 
the two tests prevented a statistical comparison of the means of the 
log removal values of the two CCL viruses at each pH value. However, 
it was apparent that FCV was removed to a greater extent than Ad4. 
Furthermore, there was an increase in removal of viruses between pH 
6.0 and 5.5 for the first CCL virus experiment (Figure 2), thereby 
indicating that an optimal pH for virus removal might be less than 6.0. 
Practical limitations effectively impart a lower pH boundary of 5;2 thus, 
the recommended pH range was 5−6.  
 
Data from the first CCL virus experiment indicate that the four 
bacteriophages are not appropriate CCL virus surrogates given that, in 
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many cases, the bacteriophages were removed more efficiently. 
However, the results of the second CCL virus experiment show that 
the CCL viruses were removed to a greater extent than the 
bacteriophages. Thus, the bacteriophages were not eliminated as 
potential CCL surrogates. It would be beneficial to conduct future 
studies to confirm the suitability of the bacteriophages as potential 
CCL virus surrogates.  
 
In summary, bench-scale testing demonstrated that the optimal 
conditions for enhanced coagulation were 40 mg/L FeCl3 and a pH 
between 5 and 6. These conditions resulted in maximum removals of 
2.58 log units of adenovirus type 4, 2.50 log units of feline calicivirus, 
2.32 log units of MS2, 1.75 log units of PRD1, 1.52 log units of phi-
X174, 2.49 log units of fr, and 56% of DOC.  
 
Pilot-Plant Tests.  
 
The pilot plant was operated at a coagulant dose of 40 mg/L 
FeCl3 and a target pH between 5 and 6 based on the optimization 
experiments. The pilot-scale study satisfied the USEPA's DOC removal 
guidelines3 (Table 12 in the Supporting Information). The complete 
results of the chemical analyses for the pilot-plant experi ments are 
provided in Table 12 in the Supporting Information.  
 
The log removal values of the bacteriophages are listed in Table 
2. Following filtration, fr was removed to the greatest extent at the 
high flow rate of 0.5 gpm (10 gpm/ft2), followed by PRD1, MS2, and 
phi-X174. At the low flow rate of 0.25 gpm (5 gpm/ft2), PRD1 was 
removed to the greatest extent, followed by MS2, fr, and phi-X174. 
The pilot-plant removals represented physical removal by coagulation, 
sedimentation, and filtration, whereas the jar-test data did not include 
filtration. Jar-test results compare to the settled water (prior to 
filtration) for the pilot-plant experiments. For the settled water, fr was 
removed to the greatest extent, followed by MS2, PRD1, and phi-
X174. The trend in virus removals (MS2 and fr > phi-X174 and PRD1) 
was consistent between bench- and pilot-scale testing; however, pilot-
plant removals exceeded bench-scale removals, which is consistent 
with previous reports.34  
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Table 2.  Log Removal Values of Bacteriophages at Different Stages of the 
Pilot Plant 
  low flow rate:a 0.25 gpm (5 gpm/ft2
) 
high flow rate:b 0.5 gpm (10 gpm/ft2
) 
bacteriophag
e 
settled water filtered water settled water filtered water  
MS2  3.94  4.60  4.28  6.87  
PRD1  3.73  6.67  4.03  7.14  
phi-X174  3.28  3.94  3.53  4.47  
fr  3.97  4.54  4.34  7.87 
a Turbidity, 13.2−17.7 NTU; pH, 8.25; alkalinity, 152 mg/L as CaCO3; DOC, 4.86 
mg/L.b Turbidity, 14−19 NTU; pH, 8.2−8.25; alkalinity, 147−152 mg/L as CaCO3; 
DOC, 4.86 mg/L. 
There was a statistically significant difference between the 
removals of the bacteriophages at the high and low flow rates, except 
for the overall removal of PRD1 and the removal of fr by sedimentation 
(P ≤ 0.01) (Table 13 in the Supporting Information). The low flow rate 
should provide a better degree of removal; however, the data indicate 
that greater bacteriophage removals were achieved at the high flow 
rate. One possible explanation is the difference in initial water quality, 
which can affect statistical analyses; therefore, the relative efficacy of 
removal for the different water flow rates was not considered 
conclusive.  
 
In summary, the results of the treatment optimization jar tests 
indicated that an optimal coagulant dose for DOC removal was 40 
mg/L FeCl3 with pH adjustment to between 5 and 6. Considering 
sedimentation only, MS2 and fr were removed to a greater extent than 
PRD1 and phi-X174; however, PRD1 exhibited a comparatively high 
degree of removal during filtration. Bacteriophages MS2, PRD1, phi-
X174, and fr appear to be suitable potential surrogates for FCV, with 
MS2 and fr being more representative. Adenovirus type 4 seemed to 
be more resistant to physical and chemical treatment processes than 
FCV and the four bacteriophages tested, thereby indicating that the 
bacteriophages might not be appropriate potential surrogates for Ad4.  
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